Codexis, Inc. (CDXS) vs Entera Bio Ltd. (ENTX)
A side-by-side comparison of Codexis, Inc. and Entera Bio Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDXS
Codexis, Inc.
$1.39HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENTX
Entera Bio Ltd.
$2.62HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CDXS vs ENTX
growth of $100 · dividends reinvested · last 8yCDXS -90.0% (-25.0%/yr)ENTX -58.3% (-10.4%/yr)ENTX compounded faster over this window
CDXS ENTX
CDXS vs ENTX: by the numbers
- •CDXS is the larger company ($150M vs $129M market cap).
- •Both run net losses; CDXS's is the smaller (-39.55% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | CDXS | ENTX |
|---|---|---|
| P/S ratio | 1.92 | N/A |
| P/B ratio | 4.54 | 17.77 |
Profitability
| Metric | CDXS | ENTX |
|---|---|---|
| Gross margin | 83.71% | 0.00% |
| Operating margin | -54.46% | -27450.00% |
| Net margin | -39.55% | -27235.71% |
| ROE | -93.22% | -234.42% |
| ROIC | -23.41% | -82.87% |
Growth (annualized)
| Metric | CDXS | ENTX |
|---|---|---|
| Revenue CAGR (5Y) | 0.38% | N/A |
| Total return CAGR (5Y) | -44.64% | -10.57% |
Frequently asked
- How have CDXS and ENTX total returns compared?
- Over the past 5 years, CDXS delivered -44.64% and ENTX delivered -10.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.